Award of MRFF Frontier grant & capital raising presentation
Filed with ASX · · 31 pages · English
This presentation has been prepared by 4DMedical Limited (ACN 161 684 831) (Company or 4DMedical). This presentation contains summary information about the Company, its subsidiaries and the entities, businesses and assets they own and operate (Group) and their activities current as at 4 March 2021 unless otherwise stated and the information remains subject to change without notice. This presentati
In the deck
Earlier from 4DMedical
- 4DMedical successfully completes A$40m placement
- 4DMedical-led consortium awarded $28.9m MRFF grant
- Voluntary Suspension
- 4DMedical reports 1H FY21 results
- Quarterly Activity Report and Appendix 4C for Q2 FY202
Later from 4DMedical
- S&P DJI Announces March 2021 Quarterly Rebalance
- 4DMedical raises $6m in strongly supported SPP
- Quarterly Activity Report and Appendix 4C for Q3 FY2021
- 4DMedical receives US$600k order for preclinical scanner
- Quarterly Activity Report and Appendix 4C for Q4 FY2021
Follow 4DMedical into a list and get an email when it puts out news.
Follow 4DMedical